MPD :: Myeloproliferative Disorders :: Foundation

The MPD Foundation promotes meaningful medical research into myeloproliferative disorders - Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF)

The MPD Foundation is pleased to announce an expansion of its current portfolio of grant opportunities research during 2008 Click here for more information

UCSD, TargeGen team-up on blood disease treatment

Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders - Clinical Study to Commence Late This Year

Click here for more Myeloproliferative Disorders News

The MPD Foundation's primary mission is to stimulate and finance original research in pursuit of new treatments and eventually a cure for the myeloproliferative disorders (MPD) which include polycythemia vera, essential thrombocythemia and primary myelofibrosis. As a secondary goal, the MPD Foundation hopes to use the research and therapies developed from the MPD work to benefit a broader range of blood cancers such as multiple myeloma, myelogenic leukemia and lymphocytic leukemia. Lastly, the foundation hopes to give patients and their families the information they need to manage myeloproliferative disorders and minimize the debilitating side effects until an initial cure is found.

100% of
All New Donations
Go Directly To
MPD Research

MPD Patient Event

Held at Fred Hutchinson

Cancer Center

Saturday, June 7th 2008 in Seattle, WA. Topics at the free conference include current management of myeloproliferative disorders & MDS.

Click here for details

CMPD Foundation
National Cancer Institute
MPD Research Consortium